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Differences in the Prevalence of
Chlamydia trachomatis Reported by
Two Laboratories Using the
Direct Immunofluorescence Test
To the Editor. \p=m-\Overa two-year period,
unforeseen circumstances led us to use
two different microbiology laboratories
for Chlamydia trachomatis testing by
the direct immunofluorescence method.
The large disparity in the results ob-
tained from the two laboratories illus-
trates the need for standards to ensure
the quality of this test.
Study.\p=m-\Between January 14, 1985,
and April 29, 1985, we tested patients
with and without cervicitis for the pres-
ence of C trachomatis using the direct
immunofluorescence test. Patients were
seen in three family practice offices and
a family planning center. The testing
was performed at a private microbiol-
ogy laboratory in Salt Lake City. The
rate of detection of C trachomatis in the
patients with and without symptoms of
pelvic infection was 3% (6/194). After
the study was concluded, the direct
testing for C trachomatis infections in
our family practice center reverted to a
local laboratory we had used previously.
Surprisingly, the positive rate for C tra-
chomatis in our community-based popu-
lation of women with and without signs
of cervicitis was 33% (51/156) while us¬
ing that laboratory. We subsequently
had all direct immunofluorescence tests
for C trachomatis done at the micro¬
biology laboratory used during the orig¬
inal study period and the positivity rate
for this organism by direct testing re¬
verted to 7% (16/241). Statistically, the
results from the first laboratory used
differed significantly from those of the
second laboratory (x2 = 55; P<.00001).
The results obtained at the first labora¬
tory during the two different time peri¬
ods did not differ significantly (x2 = .09;
P = .S).
Comment.—Several differences be¬
tween the two laboratories may have
influenced the accuracy of the results.
Reagents used by the laboratories came
from two different manufacturers,
which used monoclonal antibodies tar¬
geted to different binding sites of the
chlamydial organism. Furthermore,
there were discrepancies in the train¬
ing, experience, and supervision of mi-
crobiologists and technologists per¬
forming the tests. Finally, the quality
control measures used at the two sites
were not comparable.
The direct immunofluorescence test
for detecting C trachomatis has good
sensitivity and specificity when com¬
pared with McCoy cell culture tech¬
niques.1 However, without guidelines
for quality assurance in performing and
interpreting this test, the results
achieved in an individual laboratory
may not reflect the sensitivity and spe¬
cificity described in the literature. Qual¬
ity control standards are needed to en¬
sure dependable performance at labora¬
tories where this test is offered.2 Until
such standards are established, physi¬
cians using this test need to be aware of
the prevalence rates for C trachomatis
reported by the laboratory they use and
the similarities or differences between
these rates and reported rates in com¬
parable populations.
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Diabetes and Carbohydrates: The
Copper Connection
To the Editor.\p=m-\Bantleet al1 show in a
crossover study that after eight days on
diets providing approximately 35% of
energy as starch plus an additional 20%
as fructose, sucrose, or starch, dia-
betics had lower plasma glucose levels
when fructose was the added carbohy-
drate. Their work suggests that the
source of dietary carbohydrates may
affect glucose metabolism following
food consumption. Interestingly, the
animal literature has recently added
copper as a new dimension to the carbo-
hydrate/diabetes interaction. Reiser et
al2 have demonstrated that copper-defi-
cient rats have significantly higher
blood glucose levels after an oral
glucose load compared with copper-sup-
plemented rats. Adipocytes from cop-
per-deficient rats bound less insulin
than did cells from copper-fed rats, re-
gardless of the carbohydrate source.3
While copper deficiency may induce
glucose intolerance, fructose feeding
may induce clinical copper deficiency.
Human subjects fed fructose as 20% of
their diet developed biochemical evi-
dence of decreased copper status.4 In
addition, cardiac rhythm disturbances
occurred with unexpected frequency.
These cardiac dysrhythmias may have
been precipitated by the high-fructose
diet or the resultant copper deficiency.
There is growing concern that the aver¬
age American copper intake may be less
than optimal. Marginal copper status
may be exacerbated by fructose feed¬
ing.
It would appear that although species
uniqueness may exist, copper status
should be considered in long-term stud¬
ies of carbohydrates in diabetes pa¬
tients. Stated copper concentrations in
foods are inadequate for estimating
daily copper intakes. Only actual food
analysis by atomic absorption spectro-
photometry will provide accurate infor¬
mation. Since 90% to 95% of serum
copper is bound to ceruloplasmin, an
acute-phase reactant protein, another
index of copper status should be used.
Probably the best choice is Superoxide
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Patterns of Reported Age: Lack of
Digit Bias (and No Holding)
To the Editor.\p=m-\Nichols et al1 reported a
substantial digit bias (toward multiples
of five) in the age distribution of physi-
cians and plaintiffs involved inmalprac-
tice claims, and a most peculiar bias
toward the single ages of 39 and 59.
They advised that "physicians and oth-
ers concerned with age-related prob-
lems should be aware of this when col-
lecting and analyzing data."
Since age is nearly always a critical
variable in epidemiologic studies, it is
important to know whether this is a
widespread phenomenon. The Cancer
Prevention Study II (CPS-II)2 is a six\x=req-\
year follow-up study of over 1.2 million
Downloaded From: http://jama.jamanetwork.com/ by a Columbia University User  on 09/06/2014
40 50 60 70
Age at Enrollment, y
Age distribution of all male subjects (N = 470 846; dashed line) and male physicians (N = 8893;
solid line) aged 45 to 85 years (inclusive) at time of enrollment in Cancer Prevention Study II in
1982.
men and women, mostly aged 45 years
and older. We recently reported the
smoking habits of physicians in CPS-II
by age and sex.3 The Figure shows the
age distribution for all 470 846 men and
for 8893 male physicians aged 45 to 85
years (inclusive) when they were en-
rolled in CPS-II in late 1982. Corre-
sponding distributions for all women
and for female physicians were similar.
The distribution for all men is mono-
tonic until age 52 years, then shows
three relatively small single-year fluc¬
tuations from monotonicity at 53, 56,
and 64 years. The distribution for the
physicians shows larger fluctuations,
with unexpected peaks at even-num¬
bered ages (50, 52, 54, 58, 62, and 64
years). The observed year-to-year fluc¬
tuations are trivial and of no epidemio-
logic consequence. These fluctuations
are larger in the physician subsample
than in the group as a whole because the
number of physicians is comparatively
small.
Nichols et al, like us, have measured
the prevalence of age in specific popula¬
tions. Prevalence is determined by year
of birth and survival to study time, and
is also affected by selection factors.
Birth rates may fluctuate from one year
to another, different diseases may at¬
tack successive birth cohorts at differ¬
ent rates, and the technology for curing
potentially fatal diseases does not
change smoothly. Therefore, there is no
a priori reason to expect a perfectly
smooth distribution of birth years in a
cross-sectional study population.
We know of several factors influenc¬
ing participation in CPS-II, but none
that would affect age at the level of
single years. Neither among the 1.2
million total subjects nor among the
11000 male and female physicians did we
see any evidence of the gross 39/59 bias
reported by Nichols et al.
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Venous Catheter\p=m-\Related
Thrombosis and Infection
To the Editor.\p=m-\Thereport by Chak-
ravarthy et al1 in JAMA describes an
interesting cardiac complication of
chronic central venous access but
misses the true lesson of the case, the
prevention and treatment of catheter\x=req-\
related thrombosis and infection. Fever
and evidence for central venous throm-
bosis were present for months prior to
the terminal hospitalization of the pa-
tient. It is therefore not surprising that
advanced venous thrombosis with ex-
tension to the tricuspid valve was found.
The authors fail to discuss the diagnosis
of the underlying problem, catheter\x=req-\
related septic central venous throm-
bosis.
The diagnosis of catheter-related sep-
tic central venous thrombosis is predi-
cated on symptoms and signs of sys-
temic sepsis, blood cultures that
continue to be positive even after cathe-
ter removal, and central venous throm-
bosis, best confirmed by venography.2
The syndrome is probably underdiag-
nosed in the seriously ill population
at risk with prolonged catheterization,
and no more than 50 well-documented
cases have been described in the medi¬
cal literature. The treatment is removal
of the offending catheter, anticoagula-
tion therapywith heparin to limit exten¬
sion of the thrombosis, and a prolonged
course of intravenous antibiotics to
treat the endovascular infection. Had
this complication of a Hickman catheter
been recognized, the patient might have
survived.
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Dr Mom
To the Editor.\p=m-\"DrMom"1 found only
exhaustion and frustration as she tried
to raise a family and pursue a career in
medicine. Yet there are some among us,
male and female physicians alike, who
are enjoying both family and career at
the same time.
Most of us rely on the support of our
spouses, and together we plan our ca-
reer choices to meet the needs of both
individuals. Of course, if one spouse
chooses to pursue a position that re-
quires truly "workaholic" dedication,
that person\p=m-\maleor female\p=m-\can
meet the children after high school
graduation. Others of us find a niche
that allows one to find professional and
family satisfaction.
We are both full-time pediatricians,
with the hours and on-call schedule that
this implies. We work together, and
every responsibility in our lives is taken
by the more willing soul, be it laundry
or a neonatal resuscitation. Our chil-
dren successfully went from day care to
school-age, and we doubt there are hap¬
pier or more well-adjusted children, or a
closer family, to be found anywhere.
Our situation is not unique. We held
other positions before we entered pri¬
vate practice, and we would have found
other solutions for our needs ifwe were
elsewhere today.
Stephen K. Katz, MD
Barbara L. Katz, MD
Brick, NJ
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To the Editor.\p=m-\Itake issue with the
article by Dr Levy1 of North Chicago,
Ill, who said essentially that one could
not be a well-adjusted physician,
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